Timna Naftali

2.8k total citations
66 papers, 1.7k citations indexed

About

Timna Naftali is a scholar working on Epidemiology, Surgery and Pharmacology. According to data from OpenAlex, Timna Naftali has authored 66 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 17 papers in Surgery and 17 papers in Pharmacology. Recurrent topics in Timna Naftali's work include Inflammatory Bowel Disease (17 papers), Cannabis and Cannabinoid Research (16 papers) and Microscopic Colitis (14 papers). Timna Naftali is often cited by papers focused on Inflammatory Bowel Disease (17 papers), Cannabis and Cannabinoid Research (16 papers) and Microscopic Colitis (14 papers). Timna Naftali collaborates with scholars based in Israel, United States and Canada. Timna Naftali's co-authors include Fred M. Konikoff, Lihi Bar‐Lev Schleider, Gila Gabay, Eva Niv, Iris Dotan, Ephraim Philip Lansky, Fabiana Benjaminov, Leah Reshef, Ido Laish and Uri Gophna and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and PLoS ONE.

In The Last Decade

Timna Naftali

64 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Timna Naftali Israel	22	679	355	353	308	305	66	1.7k
J. Næsdal Sweden	26	597 0.9×	1.3k 3.6×	1.7k 4.9×	221 0.7×	253 0.8×	54	3.0k
Matthew Coates United States	17	96 0.1×	501 1.4×	899 2.5×	347 1.1×	267 0.9×	75	1.8k
Andrés Acosta United States	38	729 1.1×	1.9k 5.4×	1.2k 3.4×	278 0.9×	580 1.9×	151	4.4k
Irene Hramiak Canada	27	218 0.3×	903 2.5×	54 0.2×	497 1.6×	567 1.9×	78	2.9k
Andrea Shin United States	25	84 0.1×	850 2.4×	1.2k 3.5×	171 0.6×	350 1.1×	76	2.1k
Suck Chei Choi South Korea	28	85 0.1×	870 2.5×	888 2.5×	131 0.4×	531 1.7×	147	2.4k
Terry F. Plasse United States	15	677 1.0×	175 0.5×	41 0.1×	135 0.4×	221 0.7×	29	1.5k
Clare J. Lee United States	21	396 0.6×	688 1.9×	42 0.1×	123 0.4×	563 1.8×	61	2.3k
Anil Minocha United States	21	76 0.1×	479 1.3×	433 1.2×	77 0.3×	123 0.4×	64	1.2k
Jens Kristoffer Hertel Norway	24	97 0.1×	721 2.0×	58 0.2×	246 0.8×	354 1.2×	88	2.1k

Countries citing papers authored by Timna Naftali

Since Specialization

Citations

This map shows the geographic impact of Timna Naftali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timna Naftali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timna Naftali more than expected).

Fields of papers citing papers by Timna Naftali

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timna Naftali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timna Naftali. The network helps show where Timna Naftali may publish in the future.

Co-authorship network of co-authors of Timna Naftali

This figure shows the co-authorship network connecting the top 25 collaborators of Timna Naftali. A scholar is included among the top collaborators of Timna Naftali based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timna Naftali. Timna Naftali is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ringel, Yehuda, et al.. (2023). Upadacitinib for Acute Severe Ulcerative Colitis. Inflammatory Bowel Diseases. 29(10). 1667–1669. 17 indexed citations

Naftali, Timna, et al.. (2022). Do inflammatory bowel disease patient preferences from treatment outcomes differ by ethnicity and gender? A cross-sectional observational study. World Journal of Clinical Cases. 10(35). 12899–12908. 1 indexed citations

Naftali, Timna, Lihi Bar‐Lev Schleider, Fabiana Benjaminov, et al.. (2021). Cannabis is associated with clinical but not endoscopic remission in ulcerative colitis: A randomized controlled trial. PLoS ONE. 16(2). e0246871–e0246871. 36 indexed citations

Matalon, Shelly Tartakover, Shahar Azar, David Meiri, et al.. (2021). Endocannabinoid Levels in Ulcerative Colitis Patients Correlate With Clinical Parameters and Are Affected by Cannabis Consumption. Frontiers in Endocrinology. 12. 685289–685289. 24 indexed citations

Laish, Ido, Lior H. Katz, Shomron Ben‐Horin, Doron Yablecovitch, & Timna Naftali. (2020). Risk of metachronous neoplasia on surveillance colonoscopy among young and older patients after polypectomy. Digestive and Liver Disease. 52(4). 427–433. 3 indexed citations

Naftali, Timna, Ariella Bar‐Gil Shitrit, Ido Laish, et al.. (2019). Sense of Coherence in People with and without Inflammatory Bowel Diseases – Is there a Difference?. Journal of Gastrointestinal and Liver Diseases. 28(1). 29–32. 2 indexed citations

Laish, Ido, et al.. (2019). Diabetes Mellitus and Age are Risk Factors of Interval Colon Cancer: A Case-Control Study. Digestive Diseases. 37(4). 291–296. 7 indexed citations

Kopylov, Uri, Irit Avni‐Biron, Yulia Ron, et al.. (2018). Effectiveness and safety of vedolizumab for maintenance treatment in inflammatory bowel disease—The Israeli real world experience. Digestive and Liver Disease. 51(1). 68–74. 21 indexed citations

Lahat, Adi, Ariella Bar‐Gil Shitrit, Timna Naftali, et al.. (2017). Vedolizumab Levels in Breast Milk of Nursing Mothers With Inflammatory Bowel Disease. Journal of Crohn s and Colitis. 12(1). 120–123. 27 indexed citations

10.

Naftali, Timna, et al.. (2016). Distinct Microbiotas are Associated with Ileum-Restricted and Colon-Involving Crohnʼs Disease. Inflammatory Bowel Diseases. 22(2). 293–302. 38 indexed citations

11.

Niv, Eva, Aharon Halak, Henit Yanai, et al.. (2016). Randomized clinical study: Partially hydrolyzed guar gum (PHGG) versus placebo in the treatment of patients with irritable bowel syndrome. Nutrition & Metabolism. 13(1). 10–10. 53 indexed citations

12.

Naftali, Timna, et al.. (2014). Cannabis for Inflammatory Bowel Disease. Digestive Diseases. 32(4). 468–474. 66 indexed citations

13.

Laish, Ido, Meytal Liberman, Timna Naftali, et al.. (2013). Increased TERC gene copy number and cells in senescence in primary sclerosing cholangitis compared to colitis and control patients. Gene. 529(2). 245–249. 7 indexed citations

14.

Arnon, Shmuel, et al.. (2013). Very early feeding in stable small for gestational age preterm infants: a randomized clinical trial. Jornal de Pediatria. 89(4). 388–393. 23 indexed citations

15.

Half, Elizabeth, Liat Mlynarsky, Timna Naftali, Fabiana Benjaminov, & Fred M. Konikoff. (2013). False Negative Fecal Occult Blood Test May Be Associated with Increased Mortality from Colorectal Cancer. Digestive Diseases and Sciences. 58(9). 2639–2645. 4 indexed citations

16.

Naftali, Timna, et al.. (2013). Cannabis Induces a Clinical Response in Patients With Crohn's Disease: A Prospective Placebo-Controlled Study. Clinical Gastroenterology and Hepatology. 11(10). 1276–1280.e1. 236 indexed citations

17.

Dotan, Iris, Arik Alper, Daniel Rachmilewitz, et al.. (2012). Maternal inflammatory bowel disease has short and long-term effects on the health of their offspring: A multicenter study in Israel. Journal of Crohn s and Colitis. 7(7). 542–550. 32 indexed citations

18.

Niv, Eva, et al.. (2005). The efficacy of ATCC 55730 in the treatment of patients with irritable bowel syndrome—a double blind, placebo-controlled, randomized study. Clinical Nutrition. 24(6). 925–931. 153 indexed citations

19.

Dishy, Victor, Leonid Feldman, Timna Naftali, et al.. (2004). The effect of sildenafil on gastric emptying in patients with end-stage renal failure and symptoms of gastroparesis. Clinical Pharmacology & Therapeutics. 76(3). 281–286. 32 indexed citations

20.

Gabay, Gila, et al.. (1999). Expression of bcl-2 in Autoimmune and Helicobacter pylori-Associated Atrophic Gastritis. Digestive Diseases and Sciences. 44(4). 680–685. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact